It may suggest that fbn2 may potentially be of interest to further explore molecular factors for treatment of fbn2 deficiency-induced macular degeneration and other forms of proliferative macular degeneration, potentially through suppressing the expression of LTBP and TGF in the retina. The gene discussed is FBN2; the disease is macular degeneration.